Cabot Microelectronics Corp. (CCMP) Financials Nov 14,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Cabot Microelectronics Corp. (CCMP) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cabot Microelectronics Corp.


Fiscal year is October-September. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 408.2M 445.44M 427.66M 433.13M 424.67M
Cost of Goods Sold (COGS) incl. D&A 204.7M 231.34M 222.79M 221.02M 221.57M
COGS excluding D&A 179.71M 207.34M 199.24M 200.56M 221.57M
Depreciation & Amortization Expense 24.99M 23.99M 23.55M 20.46M -
Depreciation 22.57M 21.27M 20.86M 17.84M -
Amortization of Intangibles 2.43M 2.72M 2.68M 2.62M -
Gross Income 203.5M 214.11M 204.87M 212.12M 203.09M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 129.49M 133.72M 137.38M 135.65M 131.29M
Research & Development 51.82M 58.04M 58.64M 61.37M 59.35M
Other SG&A 77.67M 75.69M 78.74M 74.27M 71.93M
Other Operating Expense 0 0 0 0 -
Unusual Expense 555,000 806,000 814,000 (52,000) -
EBIT after Unusual Expense (555,000) (806,000) (814,000) 52,000 -
Non Operating Income/Expense (174,000) (750,000) (1.64M) 1.2M 140,000
Non-Operating Interest Income 228,000 238,000 146,000 145,000 -
Equity in Affiliates (Pretax) - - - - -
Interest Expense 233,000 155,000 2.31M 3.64M 3.35M
Gross Interest Expense 233,000 155,000 2.31M 3.64M 3.35M
Interest Capitalized 0 0 0 0 -
Pretax Income 73.28M 78.91M 62.87M 74.22M 68.59M
Income Tax 23.82M 27.25M 22.05M 22.84M 17.84M
Income Tax - Current Domestic 15.37M 15.7M 19.98M 17.65M -
Income Tax - Current Foreign 10.6M 6.62M 5.59M 8.3M -
Income Tax - Deferred Domestic (2.64M) 6.19M (308,000) (3.58M) -
Income Tax - Deferred Foreign 493,000 (1.26M) (3.22M) 458,000 -
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 -
Consolidated Net Income 49.46M 51.66M 40.83M 51.39M 50.75M
Minority Interest Expense 0 0 0 0 -
Net Income 49.46M 51.66M 40.83M 51.39M 50.75M
Extraordinaries & Discontinued Operations 0 0 0 0 -
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 -
Cumulative Effect - Accounting Chg 0 0 0 0 -
Discontinued Operations 0 0 0 0 -
Net Income After Extraordinaries 49.46M 51.66M 40.83M 51.39M 50.75M
Preferred Dividends 0 0 0 0 -
Net Income Available to Common 49.46M 51.66M 40.83M 51.39M 50.31M
EPS (Basic) 2.14 2.26 1.81 2.22 2.12
Basic Shares Outstanding 23.08M 22.9M 22.51M 22.92M 23.7M
EPS (Diluted) 2.13 2.20 1.75 2.14 2.04
Diluted Shares Outstanding 23.27M 23.43M 23.28M 23.76M 24.61M
EBITDA 99.01M 104.38M 91.04M 96.93M -
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brinker International Posts Solid Q1 2027 Earnings

Updated Category News Views 80

Strong Earnings Highlight a Winning Streak Brinker International, folks, has done it again. With the latest release of their first quarter fiscal 2027 results, it’s clear they’ve been hitting the right notes, especially at Chili’s. The numbers don't lie—trust me, I've seen my fair share of earnings calls, and this one's got meat on the bones. Let’s break it...

Continue Reading
E-Bike Demo Day Spurs New Jersey's Policy Insights

Updated Category News Views 79

Velotric Sets the Stage for E-Bike Insights The chatter over at Trenton has been electric—and I mean that literally. On October 29, Assemblywoman Tennille R. McCoy will open the gates of the New Jersey State House to host an E-Bike Demonstration and Education Day. The goal? To slap some sense into lawmakers' understanding of the buzzing e-bike market. Velotric, a major...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 68

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
ReachWell Revamps Platform for Better Community Reach

Updated Category News Views 79

ReachWell's Fresh Approach: A New Era Begins Become the whisper in the wind reaching ears far and wide—enter the new ReachWell. Sounds lofty? Well, it's shooting for the stars here, folks. This isn’t just some tech upgrade. It’s a whole new brand identity and a refreshed sense of purpose. These guys have tossed everything back on the drawing board, unveiling a...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 49

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 119

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

Updated Category News Views 68

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 85

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
Hallmark's Holiday Magic: Cards, Ornaments, Joy

Updated Category News Views 205

Hallmark's Seasonal Bonanza: Cards, Gifts, and More It's that time again when Hallmark rolls out the holiday carpet, the red one you usually just see in front of fancy theaters. Greeting cards, gifts, Keepsake Ornaments, and those nostalgic holiday flicks on Hallmark Channel—it's a full-on festive fiesta. But it's not just about shoving a card in an envelope; it's about...

Continue Reading

Top 5 Most Recently Viewed Articles

Rgenta Therapeutics Presents Innovative Data on RGT-61159

Updated Category News Views 192

Rgenta Therapeutics Unveils Preclinical Data on RGT-61159 WOBURN, Mass. – Rgenta Therapeutics, a pioneering biotechnology firm focused on the development of small molecule drugs targeting RNA for cancer and neurological disorders, has made an exciting announcement regarding its lead program, RGT-61159. This promising small molecule inhibitor, which selectively targets...

Continue Reading
TriMas Packaging Showcases Innovations at Upcoming Trade Events

Updated Category News Views 122

TriMas Packaging's Participation in Major Trade Shows TriMas Packaging, a leading group under TriMas (NASDAQ: TRS), is thrilled to announce its involvement in two prominent trade exhibitions. At these events, the company will display its extensive range of innovative and eco-friendly dispensing and closure product solutions that have garnered attention in the industry....

Continue Reading
Understanding Apollo Global Management's Recent Market Trends

Updated Category News Views 109

Understanding Apollo Global Management's Recent Market Trends The market is currently witnessing a notable shift in investor sentiment towards Apollo Global Management (NYSE: APO). This trend is not only striking but worth examining closely for anyone interested in market movements. Recent tracking of options activity has highlighted an interesting wave of bullish...

Continue Reading
Capricor Faces Securities Fraud Lawsuit: Investor Action Key

Updated Category News Views 16

Investors Take the Stage in Capricor Securities Case Here's something that'll make any shareholder's pulse quicken: Capricor Therapeutics, Inc. (NASDAQ: CAPR) is caught in a whirlwind of legal drama, and it's no soap opera. Rather, it's a class action lawsuit, brought forth by the vigilant folks over at Schall, Brown & Schwartz LLP ('SBS'), aimed squarely at alleged...

Continue Reading
Broad Arrow Auctions Collects $14.5 Million in Sales Triumph

Updated Category News Views 333

Broad Arrow Auctions Kicks Off a Successful Year Broad Arrow Auctions, an esteemed arm of Hagerty, recently embarked on its 2025 auction calendar with a remarkable showcase—the Academy of Art University Collection Auction. Held at the university's museum facilities, this auction captured the attention of classic car enthusiasts and collectors alike. A Glance at the...

Continue Reading